SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.3980/j.issn.1672-5123.2017.3.3 |
Resumo: | AIM: To investigate the changes in spectral domain optical coherence tomography (SD-OCT) quantitative and qualitative parameters in a group of patients with age-related macular degeneration (AMD) that underwent bevacizumab intravitreal injections (IV). We assessed if one or more of these parameters can be used as prognostic factors of the post treatment visual acuity (VA). METHODS: Totally 66 eyes of 61 patients, with treatment naive AMD, that were treated with at least 3 monthly bevacizumab IV, were retrospectively studied. SD-OCT quantitative [central foveal thickness (CFT), external limiting membrane (ELM) and ellipsoid zone (EZ) lengths] and qualitative parameters were studied and compared before and after IV. We also tried to establish correlation between these parameters and before/after treatment VA. RESULTS: Mean VA (logMAR), CFT (μm), ELM length(μm) and EZ length (μm) changed from pre-IV values of 0.62±0.41, 419.3±110.0, 378.2±377.2 and 156.4±253.7 to post-IV values of 0.53±0.44, 325.8±117.9, 547.1±421.5 and 173.1±207.1. There was correlation between pre-IV VA and pre-IV CFT (rs=0.27), ELM length (rs=-0.30) and ELM disruption (rs=0.43). There was also correlation between post-IV VA and post-IV ELM length (rs=-0.40). Post-IV VA showed correlation with pre-IV VA (rs=0.66), ELM length (rs=-0.35) and ELM disruption (rs=0.46). CONCLUSION: In our study group pre-IV VA, ELM length and ELM disruption can be used as post-IV VA prognostic factors. Copyright 2017 by the IJO Press. |
id |
RCAP_3a8171167512660acac59253868d4434 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/24604 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatmentAge-related macular degenerationEllipsoid zoneExternal limiting membraneOptical coherence tomographyVisual acuitybevacizumabage related macular degenerationagedArticlecentral corneal thicknessellipsoid zoneexternal limiting membranefemalefollow uphumanmajor clinical studymaleretina detachmentretina fovearetrospective studyspectral domain optical coherence tomographysubretinal neovascularizationvisual acuityvisual system parametersAIM: To investigate the changes in spectral domain optical coherence tomography (SD-OCT) quantitative and qualitative parameters in a group of patients with age-related macular degeneration (AMD) that underwent bevacizumab intravitreal injections (IV). We assessed if one or more of these parameters can be used as prognostic factors of the post treatment visual acuity (VA). METHODS: Totally 66 eyes of 61 patients, with treatment naive AMD, that were treated with at least 3 monthly bevacizumab IV, were retrospectively studied. SD-OCT quantitative [central foveal thickness (CFT), external limiting membrane (ELM) and ellipsoid zone (EZ) lengths] and qualitative parameters were studied and compared before and after IV. We also tried to establish correlation between these parameters and before/after treatment VA. RESULTS: Mean VA (logMAR), CFT (μm), ELM length(μm) and EZ length (μm) changed from pre-IV values of 0.62±0.41, 419.3±110.0, 378.2±377.2 and 156.4±253.7 to post-IV values of 0.53±0.44, 325.8±117.9, 547.1±421.5 and 173.1±207.1. There was correlation between pre-IV VA and pre-IV CFT (rs=0.27), ELM length (rs=-0.30) and ELM disruption (rs=0.43). There was also correlation between post-IV VA and post-IV ELM length (rs=-0.40). Post-IV VA showed correlation with pre-IV VA (rs=0.66), ELM length (rs=-0.35) and ELM disruption (rs=0.46). CONCLUSION: In our study group pre-IV VA, ELM length and ELM disruption can be used as post-IV VA prognostic factors. Copyright 2017 by the IJO Press.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNNoronha, M.Moura-Coelho, N.Gomes, T.Flores, R.Medeiros, M.D.2017-10-25T22:00:12Z2017-03-082017-03-08T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article5application/pdfhttps://doi.org/10.3980/j.issn.1672-5123.2017.3.3eng1672-5123PURE: 3226889https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014812834&doi=10.3980%2fj.issn.1672-5123.2017.3.3&partnerID=40&md5=3086a343069a5611c267827e40d51276https://doi.org/10.3980/j.issn.1672-5123.2017.3.3info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:12:44Zoai:run.unl.pt:10362/24604Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:28:04.696473Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment |
title |
SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment |
spellingShingle |
SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment Noronha, M. Age-related macular degeneration Ellipsoid zone External limiting membrane Optical coherence tomography Visual acuity bevacizumab age related macular degeneration aged Article central corneal thickness ellipsoid zone external limiting membrane female follow up human major clinical study male retina detachment retina fovea retrospective study spectral domain optical coherence tomography subretinal neovascularization visual acuity visual system parameters |
title_short |
SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment |
title_full |
SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment |
title_fullStr |
SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment |
title_full_unstemmed |
SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment |
title_sort |
SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment |
author |
Noronha, M. |
author_facet |
Noronha, M. Moura-Coelho, N. Gomes, T. Flores, R. Medeiros, M.D. |
author_role |
author |
author2 |
Moura-Coelho, N. Gomes, T. Flores, R. Medeiros, M.D. |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Noronha, M. Moura-Coelho, N. Gomes, T. Flores, R. Medeiros, M.D. |
dc.subject.por.fl_str_mv |
Age-related macular degeneration Ellipsoid zone External limiting membrane Optical coherence tomography Visual acuity bevacizumab age related macular degeneration aged Article central corneal thickness ellipsoid zone external limiting membrane female follow up human major clinical study male retina detachment retina fovea retrospective study spectral domain optical coherence tomography subretinal neovascularization visual acuity visual system parameters |
topic |
Age-related macular degeneration Ellipsoid zone External limiting membrane Optical coherence tomography Visual acuity bevacizumab age related macular degeneration aged Article central corneal thickness ellipsoid zone external limiting membrane female follow up human major clinical study male retina detachment retina fovea retrospective study spectral domain optical coherence tomography subretinal neovascularization visual acuity visual system parameters |
description |
AIM: To investigate the changes in spectral domain optical coherence tomography (SD-OCT) quantitative and qualitative parameters in a group of patients with age-related macular degeneration (AMD) that underwent bevacizumab intravitreal injections (IV). We assessed if one or more of these parameters can be used as prognostic factors of the post treatment visual acuity (VA). METHODS: Totally 66 eyes of 61 patients, with treatment naive AMD, that were treated with at least 3 monthly bevacizumab IV, were retrospectively studied. SD-OCT quantitative [central foveal thickness (CFT), external limiting membrane (ELM) and ellipsoid zone (EZ) lengths] and qualitative parameters were studied and compared before and after IV. We also tried to establish correlation between these parameters and before/after treatment VA. RESULTS: Mean VA (logMAR), CFT (μm), ELM length(μm) and EZ length (μm) changed from pre-IV values of 0.62±0.41, 419.3±110.0, 378.2±377.2 and 156.4±253.7 to post-IV values of 0.53±0.44, 325.8±117.9, 547.1±421.5 and 173.1±207.1. There was correlation between pre-IV VA and pre-IV CFT (rs=0.27), ELM length (rs=-0.30) and ELM disruption (rs=0.43). There was also correlation between post-IV VA and post-IV ELM length (rs=-0.40). Post-IV VA showed correlation with pre-IV VA (rs=0.66), ELM length (rs=-0.35) and ELM disruption (rs=0.46). CONCLUSION: In our study group pre-IV VA, ELM length and ELM disruption can be used as post-IV VA prognostic factors. Copyright 2017 by the IJO Press. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-10-25T22:00:12Z 2017-03-08 2017-03-08T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.3980/j.issn.1672-5123.2017.3.3 |
url |
https://doi.org/10.3980/j.issn.1672-5123.2017.3.3 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1672-5123 PURE: 3226889 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014812834&doi=10.3980%2fj.issn.1672-5123.2017.3.3&partnerID=40&md5=3086a343069a5611c267827e40d51276 https://doi.org/10.3980/j.issn.1672-5123.2017.3.3 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
5 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137907262357504 |